文献速递临床试验与 GCP新药、器械与细胞基因治疗研发

利伐沙班预防左髂静脉压迫支架植入后深静脉血栓的疗效与安全性研究(PLICTS):前瞻性随机对照试验方案

An efficacy and safety study of rivaroxaban for the prevention of deep vein thrombosis in patients with left iliac vein compression treated with stent implantation (PLICTS): study protocol for a prospective randomized controlled trial.
PubMed 文献 · Trials · 2020-09-29

本研究为多中心随机对照试验,计划从9家医院招募224例血栓性左髂静脉压迫综合征患者,随机分为利伐沙班组与华法林加那曲肝素组,主要终点为支架闭塞率,旨在比较两种抗凝方案的疗效与安全性。

要点

  • 比较利伐沙班与华法林加那曲肝素在支架植入后的抗凝效果。
  • 主要终点为支架闭塞率,次要终点包括生活质量、死亡及出血等。
  • 利伐沙班无需实验室监测,可能简化抗凝治疗。

核心结论

  • 本研究旨在为利伐沙班在左髂静脉压迫支架植入后抗血栓治疗中的疗效和安全性提供可靠的循证临床证据。

研究设计与样本

  • 多中心随机对照试验,计划从9家医院招募224例血栓性左髂静脉压迫综合征患者。
  • 患者随机分入实验组(利伐沙班)或对照组(华法林加那曲肝素)。

关键数值与推荐

  • 主要结局为支架闭塞率。
  • 次要结局包括生活质量量表调查结果、全因死亡率、抗凝相关死亡率以及支架移位/断裂、血栓形成、出血和其他血管事件的发生比例。

临床怎么用

  • 若证实利伐沙班有效且安全,可为支架植入后抗凝提供无需实验室监测的简化方案。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Balloon dilatation with stent implantation has been proved to be an effective option for left iliac vein compression syndrome (LIVCS), but thrombosis may still occur after the operation. Currently, warfarin is used for anticoagulant therapy, but long-term monitoring is required, while rivaroxaban does not need laboratory monitoring, which can simplify treatment. Therefore, this study aimed to compare the efficacy and safety of rivaroxaban and warfarin in anticoagulation. METHODS: This study is a multicenter, randomized controlled trial. We will recruit 224 patients with thrombotic LIVCS from 9 hospitals. Moreover, these patients will be randomized to either the experimental group (rivaroxaban) or the control group (warfarin plus nadroparin). The primary outcome is stent occlusion rate. Secondary outcomes are quality of life scale survey results, all-cause mortality, anticoagulation-related mortality, and the proportion of participants with stent displacement/fracture, thrombosis, hemorrhage, and other vascular events. DISCUSSION: This study will provide reliable, evidence-based clinical evidence for the efficacy and safety of rivaroxaban antithrombotic therapy after stent implantation. TRIAL REGISTRATION: ClinicalTrials.gov NCT04067505 . Registered on August 26, 2019.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Li M, Zhang L, Zhang K, et al. An efficacy and safety study of rivaroxaban for the prevention of deep vein thrombosis in patients with left iliac vein compression treated with stent implantation (PLICTS): study protocol for a prospective randomized controlled trial. Trials. 2020. PMID: 32993773. doi:10.1186/s13063-020-04742-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。